Target intelligence / Profile preview

Pilosebaceous follicular epithelium

Molecular classification
Other
01

Overview

The pilosebaceous follicular epithelium refers to the epithelial lining of the pilosebaceous follicle, a structural unit of the skin that includes the hair follicle, sebaceous gland, and arrector pili muscle[1][2][4][6]. This epithelium undergoes cyclical changes alongside hair growth (anagen, catagen, telogen), participates in the production and secretion of sebum, and houses epidermal stem cells—important for both normal cellular turnover and after injuries[1][3]. While not a direct drug target, the compartment as a whole is pivotal in dermatological diseases such as acne, folliculitis, and alopecia, and therapy often involves modulation of its associated glandular or follicular functions rather than action at a specific receptor or molecular target. Note: The term “pilosebaceous follicular epithelium” is uncommon and not recognized in standard pharmacology or molecular biology nomenclature; “pilosebaceous follicle” is preferred. There is no canonical abbreviation, and it should not be listed as a molecular target; rather, it represents a multicellular anatomical structure.

Other names
Pilosebaceous unit epitheliumHair follicle epithelium (context-dependent)Follicular epithelium (context-dependent)
02

Mechanism of action

Modulation of keratinization - Inhibition of sebaceous gland activity - Antimicrobial action - Anti-inflammatory action

03

Biological functions

Skin protectionBarrier against environmental stressorsSebum productionTemperature regulationSensory functionsHair growth and cycling
04

Disease associations

AcneHair loss (alopecia)DandruffFolliculitisSeborrheic dermatitisOther skin disorders
05

Safety considerations

Skin irritationAtrophy (with topical corticosteroids)DrynessHormonal derangement (in systemic therapies)Dysbiosis of normal skin floraScarring or changes in pigmentation (rare, related to aggressive interventions)
06

Interacting drugs

Retinoids (e.g., tretinoin, isotretinoin)

4 more in the full profile.

07

Biomarkers

Cytokeratin 19Cytokeratin 15CD200

Beyond the preview

Go deeper on Pilosebaceous follicular epithelium.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Pilosebaceous follicular epithelium.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call